Skip to main content
SpringerLink
Log in

Soluble II-2 receptor serum levels — a marker for disease progression in patients with HIV-1 infection

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

Serum levels of soluble II-2 receptors (sII-2R) were measured in 88 patients with HIV infection, 28 patients from high-risk groups, and 28 normal donors. Elevated sII-2R levels were found in 46% of asymptomatic seropositive patients, in 68% of patients with persistent generalized lymphadenopathy, and in 81% of patients with AIDS. Mean sII-2R values increased with the progression of the disease and were most pronounced in patients with AIDS. A close correlation was found between sII-2R levels and beta2-microglobulin (p<0.0001) and other prognostic parameters known to parallel clinical activity. In addition to being a valuable parameter in monitoring the course of the HIV infection, elevated sII-2R levels may also be involved in the down-regulation of II-2-dependent immune functions in AIDS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adler WH, Nagel JE, Bender BS, Kittur D, Winchurch R, Johnson J (1987) Serum interleukin-2 receptor levels in AIDS patients. Abstract III International conference on acquired immunodeficiency syndrome (AIDS). 1–5 June 1987, Washington DC, p 130

  2. Andrew ME, Churilla AM, Malek TR, Braciale VL Braciale TJ (1985) Activation of virus-specific CTL clones: antigen-dependent regulation of interleukin-2 receptor expression. J Immunol 134:920–925

    Google Scholar 

  3. Bhalla RB, Safai B, Pahwa S, Schwartz MK (1985) 302-1 as a prognostic marker for development of AIDS. Clin Chemistry 31:1411–1412

    Google Scholar 

  4. Burkes RL, Abo W, Levine AM, Linker-Israeli M, Parker JW, Gill PS, Krailo M, Horwitz DA (1987) Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome. Cancer 59:731–738

    Google Scholar 

  5. Cantrell DA, Smith KA (1983) Transient expression of interleukin-2 receptors. Consequences for T cell growth. J Exp Med 158:1895–1911

    Google Scholar 

  6. Centers for Disease Control (1986) Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 30:305–308

    Google Scholar 

  7. Diamanstein T, Osawa H (1986) The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies. Immunol Rev 92:5–27

    Google Scholar 

  8. Donnelly RP, Tsang KJ, Galbraith GMP, Wallace JI (1986) Inhibition of interleukin-2 induced T-cell proliferation by sera from patients with the acquired immunodeficiency syndrome. J Clin Immunol 6:92–101

    Google Scholar 

  9. Francioli P, Clement F, Glausner MP (1984) 302-2: a sensitive non-specific marker of acquired immunodeficiency syndrome. Eur J Clin Microbiol 3:68–69

    Google Scholar 

  10. Grabstein KS, Dower S, Gillis S, Urdal D, Larsen A (1986) Expression of interleukin-2, interferon-gamma and the Il-2 receptor by human peripheral blood lymphocytes. J Immunol 136:4503–4508

    Google Scholar 

  11. Greene WC, Leonhard WJ, Depper JM, Nelson DL, Waldmann TA (1986) The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med 105:560–572

    Google Scholar 

  12. Holter W, Goldman CK, Casabo L, Nelson DL, Greene WC, Waldmann TA (1987) Expression of functional Il-2 receptors by lipopolysaccharide and interferon-τ stimulated human monocytes. J Immunol 138:2917–2922

    Google Scholar 

  13. Kaplan DR, Braciale VL, Braciale TJ (1984) Antigen-dependent regulation of interleukin 2 receptor on cloned human cytotoxic T lymphocytes. J Immunol 133:1966–1969

    Google Scholar 

  14. Kapp A, Kirnbauer R, Luger TA, Schöpf E (1988) Altered production of immuno-modulating cytokines in patients with atopic dermatitis. Abstract 18th Annual Meeting European Society for Dermatological Research, Munich, 19–22 June 1988. J Invest Dermatol 91:398

    Google Scholar 

  15. Kaudewitz P, Josimovic-Alasevi O, Diamantstein T, Eckert F, Klepzig K, Burg G (1988) Soluble II-2R receptor serum levels in cutaneous T cell lymphoma — correlation with clinical status and II-2 receptor status in cutaneous infiltrates. Abstract 18th Annual Meeting European Society for Dermatological Research, Munich, 19–22 June 1988. J Invest Dermatol 91:386

    Google Scholar 

  16. Kloster BE, John PA, Miller LE, Rubin LA, Nelson DL, Blair DC, Tomar RH (1987) Soluble interleukin-2 receptors are elevated in patients with AIDS or at risk of developing AIDS. Clin Immunol Immunopathol 45:440–446

    Google Scholar 

  17. Lafreniere R, Rosenberg SA (1985) Successful immunotherapy of experimental hepatic metastases with lymphokineactivated killer cells and recombinant II-2. Cancer Res 45:3735–3741

    Google Scholar 

  18. Lifson JD, Benike CJ, Mark DF, Koths K, Engleman EG (1984) Human recombinant interleukin-2 partly reconstitutes deficient in-vitro immune responses of lymphocytes from patients with AIDS. Lancet 1:698–702

    Google Scholar 

  19. Lowenthal JW, Tougne C, Mac-Donald R, Smith KA, Nabholz M (1985) Antigenic stimulation regulated the expression of IL 2 receptors in a cytolytic T lymphocyte clone. J Immunol 134:931–939

    Google Scholar 

  20. McCartney-Francis N, Mizel D, Allen J, Wahl L, Smith P, Folks T (1987) The Third International Conference on AIDS, Washington DC, p 84

  21. Muraguchi A, Kehrl JH, Longo DL, Volkman DJ, Smith KA, Fauci AS (1985) Interleukin-2 receptors on human B cells. J Exp Med 161:181–197

    Google Scholar 

  22. Nelson DL, Wagner DK, Marcon L, Kurman CC, Fritz ME, Crisman JM, Casabo L, Rubin LA (1987) An analysis of soluble interleukin-2 receptors in human neoplastic disorders. In: Albertini A, Lenfant C, Paoletti R (eds) Biotechnology in clinical medicine. Raven, New York, pp 277–286

    Google Scholar 

  23. Pizzolo G, Vinante F, Sinicco A, Chilosi M, Agostini C, Perini A, Zuppini B, Semenzato G, Battistella L, Foa R (1987) Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection. Diagn Clin Immunol 5:180–183

    Google Scholar 

  24. Polk BF, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, Rinaldo C, Phair J, (1987) Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 316:61–66

    Google Scholar 

  25. Prince HE, Kleinman S, Wiliams AE (1988) Soluble II-2 receptor levels in serum from blood donors seropositive for HIV. J Immunol 140:1139–1141

    Google Scholar 

  26. Reiher WE, Blalock JE, Brunck TK (1986) Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin-2. Proc Natl Acad Sci USA 83:9188–9192

    Google Scholar 

  27. Rook AH, Masur H, Lane HC, Frederick W, Kasahara T, Macher AB, Djeu JY, Manischewtz JF, Jackson L, Fauci AS, Quinnan GV (1983) Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with acquired immune deficiency syndrome. J Clin Invest 72:398–403

    Google Scholar 

  28. Rubin LA, Jay G, Nelson DL (1986) The released interleukin-2 receptor binds interleukin-2 efficiently. J Immunol 137:3841–3844

    Google Scholar 

  29. Rubin LA, Kurman CC, Fritz ME, Biddeson WE, Boutin B, Yarchoan R, Nelson DL (1985) Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172–3177

    Google Scholar 

  30. Schulte C, Fröschl M, Meurer M (1987) Prognostische Bedeutung von Antikörpern gegen HIV-Kernproteine bei Patienten mit Lymphadenopathie-Syndrom. Hautarzt 39:45–48

    Google Scholar 

  31. Schulte C, Meurer M, Braun-Falco O, Fröschl M, Ring J, Riethmüller G, Gürtler L (1987) Serologische und immunologische Diagnostik der HIV-1-Infektion. Dtsch Med Wochenschr 112:1687–1693

    Google Scholar 

  32. Sethi KK, Naher H (1986) Elevated titers of cell-free interleukin-2-receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome. Immunol Lett 13:179

    Google Scholar 

  33. Smith KA (1988) Interleukin-2: inception, impact, and implications. Science 240:1169–1176

    Google Scholar 

  34. Suzuki R, Handa K, Itoh K, Kuzmazi K (1983) Natural killer cells as a responder to interleukin-2. J Immunol 130:981–992

    Google Scholar 

  35. Tsang KY, Fudenberg HH, Galbraith GMP, Donnelly RP, Bishop LR, Koopmann WR (1985) Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor). Expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro. J Clin Invest 75:1538–1544

    Google Scholar 

  36. Uchiyama T, Broder S, Waldmann TA (1981) A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac(+)cells. J Immunol 126:1393–1397

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatologische Klinik und Poliklinik der Ludwig-Maximilians-Universität, Frauenlobstr. 9-11, Munich, Federal Republic of Germany

    C. Schulte & M. Meurer

Authors
  1. C. Schulte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Meurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulte, C., Meurer, M. Soluble II-2 receptor serum levels — a marker for disease progression in patients with HIV-1 infection. Arch Dermatol Res 281, 299–303 (1989). https://doi.org/10.1007/BF00412971

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00412971

Key words

Search

Navigation